Enterohemorrhagic E. coli (EHEC) causes severe diseases in humans worldwide. One of its virulence factors is EspP, which belongs to the serine protease autotransporters of Enterobacteriaceae (SPATE) family. In this review we recapitulate the current data on prevalence, biogenesis, structural properties and functionality. EspP has been used to investigate mechanistic details of autotransport, and recent studies indicate that this transport mechanism is not autonomous but rather dependent on additional factors. Currently, five subtypes have been identified (EspPα-EspPε), with EspPα being associated with highly virulent EHEC serotypes and isolates from patients with severe disease. EspPα has been shown to degrade major proteins of the complement cascade, namely C3 and C5 and probably interferes with hemostasis by cleavage of coagulation factor V. Furthermore, EspPα is believed to contribute to biofilm formation perhaps by polymerization to rope-like structures. Together with the proteolytic activity, EspPα might ameliorate host colonization and interfere with host response.
References
[1]
Brunder, W.; Schmidt, H.; Karch, H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 1997, 24, 767–778.
[2]
Brockmeyer, J.; Spelten, S.; Kuczius, T.; Bielaszewska, M.; Karch, H. Structure and function relationship of the autotransport and proteolytic activity of EspP from Shiga toxin-producing Escherichia coli. PLoS One 2009, 4, e6100.
[3]
Djafari, S.; Ebel, F.; Deibel, C.; Kramer, S.; Hudel, M.; Chakraborty, T. Characterization of an exported protease from Shiga toxin-producing Escherichia coli. Mol. Microbiol. 1997, 25, 771–784, doi:10.1046/j.1365-2958.1997.5141874.x.
[4]
Pohlner, J.; Halter, R.; Beyreuther, K.; Meyer, T.F. Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 1987, 325, 458–462.
[5]
Desvaux, M.; Parham, N.J.; Henderson, I.R. The autotransporter secretion system. Res. Microbiol. 2004, 155, 53–60, doi:10.1016/j.resmic.2003.10.002.
[6]
Henderson, I.R.; Navarro-Garcia, F.; Desvaux, M.; Fernandez, R.C.; Ala’Aldeen, D. Type V protein secretion pathway: The autotransporter story. Microbiol. Mol. Biol. Rev. 2004, 68, 692–744, doi:10.1128/MMBR.68.4.692-744.2004.
[7]
Ieva, R.; Bernstein, H.D. Interaction of an autotransporter passenger domain with BamA during its translocation across the bacterial outer membrane. Proc. Natl. Acad. Sci. USA 2009, 106, 19120–19125, doi:10.1073/pnas.0907912106.
[8]
Ruiz-Perez, F.; Henderson, I.R.; Leyton, D.L.; Rossiter, A.E.; Zhang, Y.; Nataro, J.P. Roles of periplasmic chaperone proteins in the biogenesis of serine protease autotransporters of Enterobacteriaceae. J. Bacteriol. 2009, 191, 6571–6583.
[9]
Ruiz-Perez, F.; Henderson, I.R.; Nataro, J.P. Interaction of FkpA, a peptidyl-prolyl cis/trans isomerase with EspP autotransporter protein. Gut Microbes 2010, 1, 339–344, doi:10.4161/gmic.1.5.13436.
[10]
Ieva, R.; Tian, P.; Peterson, J.H.; Bernstein, H.D. Sequential and spatially restricted interactions of assembly factors with an autotransporter beta domain. Proc. Natl. Acad. Sci. USA 2011, 108, E383–E391.
[11]
Selkrig, J.; Mosbahi, K.; Webb, C.T.; Belousoff, M.J.; Perry, A.J.; Wells, T.J.; Morris, F.; Leyton, D.L.; Totsika, M.; Phan, M.D.; et al. Discovery of an archetypal protein transport system in bacterial outer membranes. Nat. Struct. Mol. Biol. 2012, 19, 506–510, doi:10.1038/nsmb.2261.
[12]
Leyton, D.L.; Rossiter, A.E.; Henderson, I.R. From self sufficiency to dependence: Mechanisms and factors important for autotransporter biogenesis. Nat. Rev. 2012, 10, 213–225, doi:10.1038/nrmicro2733.
[13]
Celik, N.; Webb, C.T.; Leyton, D.L.; Holt, K.E.; Heinz, E.; Gorrell, R.; Kwok, T.; Naderer, T.; Strugnell, R.A.; Speed, T.P.; et al. A bioinformatic strategy for the detection, classification and analysis of bacterial autotransporters. PLoS One 2012, 7, e43245.
[14]
Wells, T.J.; Totsika, M.; Schembri, M.A. Autotransporters of Escherichia coli: A sequence-based characterization. Microbiology 2010, 156, 2459–2469, doi:10.1099/mic.0.039024-0.
Grozdanov, L.; Raasch, C.; Schulze, J.; Sonnenborn, U.; Gottschalk, G.; Hacker, J.; Dobrindt, U. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 2004, 186, 5432–5441.
[17]
Parham, N.J.; Pollard, S.J.; Desvaux, M.; Scott-Tucker, A.; Liu, C.; Fivian, A.; Henderson, I.R. Distribution of the serine protease autotransporters of the Enterobacteriaceae among extraintestinal clinical isolates of Escherichia coli. J. Clin. Microbiol. 2005, 43, 4076–4082, doi:10.1128/JCM.43.8.4076-4082.2005.
[18]
Boisen, N.; Ruiz-Perez, F.; Scheutz, F.; Krogfelt, K.A.; Nataro, J.P. Short report: High prevalence of serine protease autotransporter cytotoxins among strains of enteroaggregative Escherichia coli. Am. J. Trop. Med. Hyg. 2009, 80, 294–301.
[19]
Yen, Y.T.; Kostakioti, M.; Henderson, I.R.; Stathopoulos, C. Common themes and variations in serine protease autotransporters. Trends Microbiol. 2008, 16, 370–379, doi:10.1016/j.tim.2008.05.003.
[20]
Dautin, N. Serine protease autotransporters of enterobacteriaceae (SPATEs): Biogenesis and function. Toxins 2010, 2, 1179–1206, doi:10.3390/toxins2061179.
[21]
Patel, S.K.; Dotson, J.; Allen, K.P.; Fleckenstein, J.M. Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli. Infect. Immun. 2004, 72, 1786–1794, doi:10.1128/IAI.72.3.1786-1794.2004.
[22]
Leyton, D.L.; Sloan, J.; Hill, R.E.; Doughty, S.; Hartland, E.L. Transfer region of pO113 from enterohemorrhagic Escherichia coli: Similarity with R64 and identification of a novel plasmid-encoded autotransporter, EpeA. Infect. Immun. 2003, 71, 6307–6319.
[23]
Navarro-Garcia, F.; Canizalez-Roman, A.; Sui, B.Q.; Nataro, J.P.; Azamar, Y. The serine protease motif of EspC from enteropathogenic Escherichia coli produces epithelial damage by a mechanism different from that of Pet toxin from enteroaggregative E. coli. Infect. Immun. 2004, 72, 3609–3621, doi:10.1128/IAI.72.6.3609-3621.2004.
[24]
Stein, M.; Kenny, B.; Stein, M.A.; Finlay, B.B. Characterization of EspC, a 110-kilodalton protein secreted by enteropathogenic Escherichia coli which is homologous to members of the immunoglobulin A protease-like family of secreted proteins. J. Bacteriol. 1996, 178, 6546–6554.
[25]
Mellies, J.L.; Navarro-Garcia, F.; Okeke, I.; Frederickson, J.; Nataro, J.P.; Kaper, J.B. espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect. Immun. 2001, 69, 315–324, doi:10.1128/IAI.69.1.315-324.2001.
[26]
Schmidt, H.; Zhang, W.L.; Hemmrich, U.; Jelacic, S.; Brunder, W.; Tarr, P.I.; Dobrindt, U.; Hacker, J.; Karch, H. Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Immun. 2001, 69, 6863–6873.
[27]
Otto, B.R.; van Dooren, S.J.; Nuijens, J.H.; Luirink, J.; Oudega, B. Characterization of a hemoglobin protease secreted by the pathogenic Escherichia coli strain EB1. J. Exp. Med. 1998, 188, 1091–1103, doi:10.1084/jem.188.6.1091.
[28]
Provence, D.L.; Curtiss, R., III. Isolation and characterization of a gene involved in hemagglutination by an avian pathogenic Escherichia coli strain. Infect. Immun. 1994, 62, 1369–1380.
[29]
Kostakioti, M.; Stathopoulos, C. Functional analysis of the Tsh autotransporter from an avian pathogenic Escherichia coli strain. Infect. Immun. 2004, 72, 5548–5554, doi:10.1128/IAI.72.10.5548-5554.2004.
[30]
Heimer, S.R.; Rasko, D.A.; Lockatell, C.V.; Johnson, D.E.; Mobley, H.L. Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect. Immun. 2004, 72, 593–597, doi:10.1128/IAI.72.1.593-597.2004.
[31]
Kobayashi, R.K.; Gaziri, L.C.; Venancio, E.J.; Vidotto, M.C. Detection of Tsh protein mucinolytic activity by SDS-PAGE. J. Microbiol. Methods 2007, 68, 654–655, doi:10.1016/j.mimet.2006.10.002.
Karch, H.; Denamur, E.; Dobrindt, U.; Finlay, B.B.; Hengge, R.; Johannes, L.; Ron, E.Z.; Tonjum, T.; Sansonetti, P.; Vicente, M. The enemy within us: Lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol. Med. 2012, 4, 841–848, doi:10.1002/emmm.201201662.
[41]
Benjelloun-Touimi, Z.; Sansonetti, P.J.; Parsot, C. SepA, the major extracellular protein of Shigella flexneri: Autonomous secretion and involvement in tissue invasion. Mol. Microbiol. 1995, 17, 123–135, doi:10.1111/j.1365-2958.1995.mmi_17010123.x.
[42]
Al-Hasani, K.; Henderson, I.R.; Sakellaris, H.; Rajakumar, K.; Grant, T.; Nataro, J.P.; Robins-Browne, R.; Adler, B. The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect. Immun. 2000, 68, 2457–2463, doi:10.1128/IAI.68.5.2457-2463.2000.
Harrington, S.M.; Sheikh, J.; Henderson, I.R.; Ruiz-Perez, F.; Cohen, P.S.; Nataro, J.P. The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect. Immun. 2009, 77, 2465–2473, doi:10.1128/IAI.01494-08.
[47]
Law, D. Virulence factors of Escherichia coli O157 and other Shiga toxin-producing E. coli. J. Appl. Microbiol. 2000, 88, 729–745, doi:10.1046/j.1365-2672.2000.01031.x.
[48]
Karmali, M.A. Infection by Shiga toxin-producing Escherichia coli: An overview. Mol. Biotechnol. 2004, 26, 117–122, doi:10.1385/MB:26:2:117.
[49]
Brockmeyer, J.; Bielaszewska, M.; Fruth, A.; Bonn, M.L.; Mellmann, A.; Humpf, H.U.; Karch, H. Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: Distribution, secretion, and proteolytic activity. Appl. Environ. Microbiol. 2007, 73, 6351–6359.
[50]
Khan, A.B.; Naim, A.; Orth, D.; Grif, K.; Mohsin, M.; Prager, R.; Dierich, M.P.; Wurzner, R. Serine protease espP subtype alpha, but not beta or gamma, of Shiga toxin-producing Escherichia coli is associated with highly pathogenic serogroups. Int. J. Med. Microbiol. 2009, 299, 247–254, doi:10.1016/j.ijmm.2008.08.006.
[51]
Oomen, C.J.; van Ulsen, P.; van Gelder, P.; Feijen, M.; Tommassen, J.; Gros, P. Structure of the translocator domain of a bacterial autotransporter. EMBO J. 2004, 23, 1257–1266, doi:10.1038/sj.emboj.7600148.
[52]
De, E.; Saint, N.; Glinel, K.; Meli, A.C.; Levy, D.; Jacob-Dubuisson, F. Influence of the passenger domain of a model autotransporter on the properties of its translocator domain. Mol. Membr. Biol. 2008, 25, 192–202, doi:10.1080/09687680701771925.
[53]
Ieva, R.; Skillman, K.M.; Bernstein, H.D. Incorporation of a polypeptide segment into the β-domain pore during the assembly of a bacterial autotransporter. Mol. Microbiol. 2008, 67, 188–201.
[54]
Oliver, D.C.; Huang, G.; Nodel, E.; Pleasance, S.; Fernandez, R.C. A conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domain. Mol. Microbiol. 2003, 47, 1367–1383.
[55]
Velarde, J.J.; Nataro, J.P. Hydrophobic residues of the autotransporter EspP linker domain are important for outer membrane translocation of its passenger. J. Biol. Chem. 2004, 279, 31495–31504, doi:10.1074/jbc.M404424200.
[56]
Economou, A.; Christie, P.J.; Fernandez, R.C.; Palmer, T.; Plano, G.V.; Pugsley, A.P. Secretion by numbers: Protein traffic in prokaryotes. Mol. Microbiol. 2006, 62, 308–319.
[57]
Leo, J.C.; Grin, I.; Linke, D. Type V secretion: Mechanism(s) of autotransport through the bacterial outer membrane. Philos. Trans. R. Soc. Lond. B 2012, 367, 1088–1101.
[58]
Peterson, J.H.; Szabady, R.L.; Bernstein, H.D. An unusual signal peptide extension inhibits the binding of bacterial presecretory proteins to the signal recognition particle, trigger factor, and the SecYEG complex. J. Biol. Chem. 2006, 281, 9038–9048.
[59]
von Heijne, G. Signal sequences. The limits of variation. J. Mol. Biol. 1985, 184, 99–105, doi:10.1016/0022-2836(85)90046-4.
[60]
Henderson, I.R.; Navarro-Garcia, F.; Nataro, J.P. The great escape: Structure and function of the autotransporter proteins. Trends Microb. 1998, 6, 370–378, doi:10.1016/S0966-842X(98)01318-3.
[61]
Szabady, R.L.; Peterson, J.H.; Skillman, K.M.; Bernstein, H.D. An unusual signal peptide facilitates late steps in the biogenesis of a bacterial autotransporter. Proc. Natl. Acad. Sci. USA 2005, 102, 221–226.
Peterson, J.H.; Tian, P.; Ieva, R.; Dautin, N.; Bernstein, H.D. Secretion of a bacterial virulence factor is driven by the folding of a C-terminal segment. Proc. Natl. Acad. Sci. USA 2010, 107, 17739–17744.
[64]
Dautin, N.; Barnard, T.J.; Anderson, D.E.; Bernstein, H.D. Cleavage of a bacterial autotransporter by an evolutionarily convergent autocatalytic mechanism. EMBO J. 2007, 26, 1942–1952, doi:10.1038/sj.emboj.7601638.
[65]
Barnard, T.J.; Gumbart, J.; Peterson, J.H.; Noinaj, N.; Easley, N.C.; Dautin, N.; Kuszak, A.J.; Tajkhorshid, E.; Bernstein, H.D.; Buchanan, S.K. Molecular basis for the activation of a catalytic asparagine residue in a self-cleaving bacterial autotransporter. J. Mol. Biol. 2012, 415, 128–142.
[66]
Dautin, N.; Bernstein, H.D. Residues in a conserved α-helical segment are required for cleavage but not secretion of an Escherichia coli serine protease autotransporter passenger domain. J. Bacteriol. 2011, 193, 3748–3756, doi:10.1128/JB.05070-11.
[67]
Kostakioti, M.; Stathopoulos, C. Role of the α-helical linker of the C-terminal translocator in the biogenesis of the serine protease subfamily of autotransporters. Infect. Immun. 2006, 74, 4961–4969, doi:10.1128/IAI.00103-06.
[68]
Tajima, N.; Kawai, F.; Park, S.Y.; Tame, J.R. A novel intein-like autoproteolytic mechanism in autotransporter proteins. J. Mol. Biol. 2010, 402, 645–656, doi:10.1016/j.jmb.2010.06.068.
[69]
Restieri, C.; Garriss, G.; Locas, M.C.; Dozois, C.M. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl. Environ. Microbiol. 2007, 73, 1553–1562.
[70]
Bugarel, M.; Martin, A.; Fach, P.; Beutin, L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: A basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 2011, 11, 142, doi:10.1186/1471-2180-11-142.
[71]
Schmidt, H.; Geitz, C.; Tarr, P.I.; Frosch, M.; Karch, H. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: Phenotypic and genetic profiling of virulence traits and evidence for clonality. J. Infect. Dis. 1999, 179, 115–123, doi:10.1086/314537.
[72]
Welinder-Olsson, C.; Badenfors, M.; Cheasty, T.; Kjellin, E.; Kaijser, B. Genetic profiling of enterohemorrhagic Escherichia coli strains in relation to clonality and clinical signs of infection. J. Clin. Microbiol. 2002, 40, 959–964.
[73]
Aktan, I.; Carter, B.; Wilking, H.; La Ragione, R.M.; Wieler, L.; Woodward, M.J.; Anjum, M.F. Influence of geographical origin, host animal and stx gene on the virulence characteristics of Escherichia coli O26 strains. J. Med. Microbiol. 2007, 56, 1431–1439, doi:10.1099/jmm.0.47311-0.
[74]
Posse, B.; De Zutter, L.; Heyndrickx, M.; Herman, L. Metabolic and genetic profiling of clinical O157 and non-O157 Shiga-toxin-producing Escherichia coli. Res. Microbiol. 2007, 158, 591–599, doi:10.1016/j.resmic.2007.06.001.
[75]
Fratamico, P.M.; Yan, X.; Caprioli, A.; Esposito, G.; Needleman, D.S.; Pepe, T.; Tozzoli, R.; Cortesi, M.L.; Morabito, S. The complete DNA sequence and analysis of the virulence plasmid and of five additional plasmids carried by Shiga toxin-producing Escherichia coli O26:H11 strain H30. Int. J. Med. Microbiol. 2011, 301, 192–203, doi:10.1016/j.ijmm.2010.09.002.
[76]
Brunder, W.; Karch, H.; Schmidt, H. Complete sequence of the large virulence plasmid pSFO157 of the sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H-strain 3072/96. Int. J. Med. Microbiol. 2006, 296, 467–474, doi:10.1016/j.ijmm.2006.05.005.
[77]
Nagano, H.; Okui, T.; Fujiwara, O.; Uchiyama, Y.; Tamate, N.; Kumada, H.; Morimoto, Y.; Yano, S. Clonal structure of Shiga toxin (Stx)-producing and β-D-glucuronidase-positive Escherichia coli O157:H7 strains isolated from outbreaks and sporadic cases in Hokkaido, Japan. J. Med. Microbiol. 2002, 51, 405–416.
[78]
Rump, L.V.; Meng, J.; Strain, E.A.; Cao, G.; Allard, M.W.; Gonzalez-Escalona, N. Complete DNA sequence analysis of enterohemorrhagic Escherichia coli plasmid pO157_2 in β-glucuronidase-positive E. coli O157:H7 reveals a novel evolutionary path. J. Bacteriol. 2012, 194, 3457–3463.
[79]
Brunder, W.; Schmidt, H.; Frosch, M.; Karch, H. The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 1999, 145, 1005–1014.
[80]
Bielaszewska, M.; Stoewe, F.; Fruth, A.; Zhang, W.; Prager, R.; Brockmeyer, J.; Mellmann, A.; Karch, H.; Friedrich, A.W. Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J. Clin. Microbiol. 2009, 47, 2061–2066.
[81]
Boerlin, P.; McEwen, S.A.; Boerlin-Petzold, F.; Wilson, J.B.; Johnson, R.P.; Gyles, C.L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 1999, 37, 497–503.
[82]
Pradel, N.; Bertin, Y.; Martin, C.; Livrelli, V. Molecular analysis of shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients and dairy samples in France. Appl. Environ. Microbiol. 2008, 74, 2118–2128.
[83]
Toszeghy, M.; Phillips, N.; Reeves, H.; Wu, G.; Teale, C.; Coldham, N.; Randall, L. Molecular and phenotypic characterisation of Extended Spectrum β-lactamase CTX-M Escherichia coli from farm animals in Great Britain. Res. Vet. Sci. 2012, 1142–1150.
[84]
Horcajo, P.; Dominguez-Bernal, G.; de la Fuente, R.; Ruiz-Santa-Quiteria, J.A.; Blanco, J.E.; Blanco, M.; Mora, A.; Dahbi, G.; Lopez, C.; Puentes, B.; et al. Comparison of ruminant and human attaching and effacing Escherichia coli (AEEC) strains. Vet. Microbiol. 2012, 155, 341–348, doi:10.1016/j.vetmic.2011.08.034.
[85]
Geue, L.; Segura-Alvarez, M.; Conraths, F.J.; Kuczius, T.; Bockemühl, J.; Karch, H.; Gallien, P. A long-term study on the prevalence of shiga toxin-producing Escherichia coli (STEC) on four German cattle farms. Epidemiol. Infect. 2002, 129, 173–185.
[86]
Khan, A.; Yamasaki, S.; Sato, T.; Ramamurthy, T.; Pal, A.; Datta, S.; Chowdhury, N.R.; Das, S.C.; Sikdar, A.; Tsukamoto, T.; et al. Prevalence and genetic profiling of virulence determinants of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle, beef, and humans, Calcutta, India. Emerg. Infect. Dis. 2002, 8, 54–62, doi:10.3201/eid0801.010104.
[87]
Nielsen, E.M.; Andersen, M.T. Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5' nuclease PCR assay. J. Clin. Microbiol. 2003, 41, 2884–2893, doi:10.1128/JCM.41.7.2884-2893.2003.
[88]
Ewers, C.; Schuffner, C.; Weiss, R.; Baljer, G.; Wieler, L.H. Molecular characteristics of Escherichia coli serogroup O78 strains isolated from diarrheal cases in bovines urge further investigations on their zoonotic potential. Mol. Nutr. Food Res. 2004, 48, 504–514, doi:10.1002/mnfr.200400063.
[89]
Geue, L.; Selhorst, T.; Schnick, C.; Mintel, B.; Conraths, F.J. Analysis of the clonal relationship of shiga toxin-producing Escherichia coli serogroup O165:H25 isolated from cattle. Appl. Environ. Microbiol. 2006, 72, 2254–2259, doi:10.1128/AEM.72.3.2254-2259.2006.
[90]
Karama, M.; Johnson, R.P.; Holtslander, R.; McEwen, S.A.; Gyles, C.L. Prevalence and characterization of verotoxin-producing Escherichia coli (VTEC) in cattle from an Ontario abattoir. Can. J. Vet. Res. 2008, 72, 297–302.
[91]
Cookson, A.L.; Bennett, J.; Nicol, C.; Thomson-Carter, F.; Attwood, G.T. Molecular subtyping and distribution of the serine protease from shiga toxin-producing Escherichia coli among atypical enteropathogenic E. coli strains. Appl. Environ. Microbiol. 2009, 75, 2246–2249, doi:10.1128/AEM.01957-08.
[92]
De Verdier, K.; Nyman, A.; Greko, C.; Bengtsson, B. Antimicrobial resistance and virulence factors in Escherichia coli from Swedish dairy calves. Acta Vet. Scand. 2012, 54, 2, doi:10.1186/1751-0147-54-2.
[93]
Madic, J.; Vingadassalon, N.; de Garam, C.P.; Marault, M.; Scheutz, F.; Brugere, H.; Jamet, E.; Auvray, F. Detection of Shiga toxin-producing Escherichia coli serotypes O26:H11, O103:H2, O111:H8, O145:H28, and O157:H7 in raw-milk cheeses by using multiplex real-time PCR. Appl. Environ. Microbiol. 2011, 77, 2035–2041.
[94]
Slanec, T.; Fruth, A.; Creuzburg, K.; Schmidt, H. Molecular analysis of virulence profiles and Shiga toxin genes in food-borne Shiga toxin-producing Escherichia coli. Appl. Environ. Microbiol. 2009, 75, 6187–6197, doi:10.1128/AEM.00874-09.
[95]
Bugarel, M.; Beutin, L.; Martin, A.; Gill, A.; Fach, P. Micro-array for the identification of Shiga toxin-producing Escherichia coli (STEC) seropathotypes associated with hemorrhagic colitis and hemolytic uremic syndrome in humans. Int. J. Food Microbiol. 2010, 142, 318–329, doi:10.1016/j.ijfoodmicro.2010.07.010.
[96]
Bosilevac, J.M.; Koohmaraie, M. Prevalence and characterization of non-O157 shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States. Appl. Environ. Microbiol. 2011, 77, 2103–2112, doi:10.1128/AEM.02833-10.
Polifroni, R.; Etcheverria, A.I.; Sanz, M.E.; Cepeda, R.E.; Kruger, A.; Lucchesi, P.M.; Fernandez, D.; Parma, A.E.; Padola, N.L. Molecular characterization of Shiga toxin-producing Escherichia coli isolated from the environment of a dairy farm. Curr. Microbiol. 2012, 65, 337–343.
[99]
Orth, D.; Ehrlenbach, S.; Brockmeyer, J.; Khan, A.B.; Huber, G.; Karch, H.; Sarg, B.; Lindner, H.; Wurzner, R. EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5. Infect. Immun. 2010, 78, 4294–4301, doi:10.1128/IAI.00488-10.
[100]
Brockmeyer, J.; Aldick, T.; Soltwisch, J.; Zhang, W.; Tarr, P.I.; Weiss, A.; Dreisewerd, K.; Muthing, J.; Bielaszewska, M.; Karch, H. Enterohaemorrhagic Escherichia coli haemolysin is cleaved and inactivated by serine protease EspPalpha. Environ. Microbiol. 2011, 13, 1327–1341.
[101]
Yamazaki, T.; Miyamoto, M.; Yamada, S.; Okuda, K.; Ishihara, K. Surface protease of Treponema denticola hydrolyzes C3 and influences function of polymorphonuclear leukocytes. Microbes Infect. 2006, 8, 1758–1763, doi:10.1016/j.micinf.2006.02.013.
[102]
Potempa, M.; Potempa, J.; Kantyka, T.; Nguyen, K.A.; Wawrzonek, K.; Manandhar, S.P.; Popadiak, K.; Riesbeck, K.; Eick, S.; Blom, A.M. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog. 2009, 5, e1000316, doi:10.1371/journal.ppat.1000316.
[103]
Park, S.Y.; Kim, K.M.; Lee, J.H.; Seo, S.J.; Lee, I.H. Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect. Immun. 2007, 75, 1861–1869, doi:10.1128/IAI.01473-06.
[104]
Kuo, C.F.; Lin, Y.S.; Chuang, W.J.; Wu, J.J.; Tsao, N. Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis. Infect. Immun. 2008, 76, 1163–1169.
[105]
Schenkein, H.A.; Fletcher, H.M.; Bodnar, M.; Macrina, F.L. Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J. Immunol. 1995, 154, 5331–5337.
[106]
Hong, Y.Q.; Ghebrehiwet, B. Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin. Immunol. Immunopathol. 1992, 62, 133–138, doi:10.1016/0090-1229(92)90065-V.
[107]
Oda, T.; Kojima, Y.; Akaike, T.; Ijiri, S.; Molla, A.; Maeda, H. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease. Infect. Immun. 1990, 58, 1269–1272.
[108]
Discipio, R.G.; Daffern, P.J.; Kawahara, M.; Pike, R.; Travis, J.; Hugli, T.E.; Potempa, J. Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5. Immunology 1996, 87, 660–667.
[109]
Wexler, D.E.; Chenoweth, D.E.; Cleary, P.P. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA 1985, 82, 8144–8148.
[110]
Duga, S.; Asselta, R.; Tenchini, M.L. Coagulation factor V. Int. J. Biochem. Cell Biol. 2004, 36, 1393–1399, doi:10.1016/j.biocel.2003.08.002.
[111]
Aldick, T.; Bielaszewska, M.; Uhlin, B.E.; Humpf, H.U.; Wai, S.N.; Karch, H. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Mol. Microbiol. 2009, 71, 1496–1508, doi:10.1111/j.1365-2958.2009.06618.x.
[112]
Brewer, H.B., Jr.; Fairwell, T.; LaRue, A.; Ronan, R.; Houser, A.; Bronzert, T.J. The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem. Biophys. Res. Commun. 1978, 80, 623–630, doi:10.1016/0006-291X(78)91614-5.
[113]
Concha, M.I.; Molina, S.A.; Oyarzún, C.; Villanueva, J.; Amthauer, R. Local expression of apolipoprotein A-I gene and a possible role for HDL in primary defence in the carp skin. Fish Shellfish Immunol. 2003, 14, 259–273, doi:10.1006/fsim.2002.0435.
[114]
Burger, D.; Dayer, J.M. High-density lipoprotein-associated apolipoprotein A-I: The missing link between infection and chronic inflammation? Autoimmun. Rev. 2002, 1, 111–117, doi:10.1016/S1568-9972(01)00018-0.
[115]
Massamiri, T.; Tobias, P.S.; Curtiss, L.K. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: Role of apolipoprotein A-I. J. Lipid Res. 1997, 38, 516–525.
[116]
Flegel, W.A.; Baumstark, M.W.; Weinstock, C.; Berg, A.; Northoff, H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect. Immun. 1993, 61, 5140–5146.
[117]
Emancipator, K.; Csako, G.; Elin, R.J. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 1992, 60, 596–601.
[118]
Schmidt, H.; Beutin, L.; Karch, H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 1995, 63, 1055–1061.
[119]
Bauer, M.E.; Welch, R.A. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 1996, 64, 167–175.
[120]
Aldick, T.; Bielaszewska, M.; Zhang, W.; Brockmeyer, J.; Schmidt, H.; Friedrich, A.W.; Kim, K.S.; Schmidt, M.A.; Karch, H. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes Infect. 2007, 9, 282–290, doi:10.1016/j.micinf.2006.12.001.
[121]
Welch, R.A. RTX toxin structure and function: A story of numerous anomalies and few analogies in toxin biology. Curr. Topics Microbiol. Immunol. 2001, 257, 85–111, doi:10.1007/978-3-642-56508-3_5.
[122]
Nagamune, K.; Yamamoto, K.; Naka, A.; Matsuyama, J.; Miwatani, T.; Honda, T. In vitro proteolytic processing and activation of the recombinant precursor of El Tor cytolysin/hemolysin (pro-HlyA) of Vibrio cholerae by soluble hemagglutinin/protease of V. cholerae, trypsin, and other proteases. Infect. Immun. 1996, 64, 4655–4658.
[123]
Garred, O.; van Deurs, B.; Sandvig, K. Furin-induced cleavage and activation of Shiga toxin. J. Biol. Chem. 1995, 270, 10817–10821, doi:10.1074/jbc.270.18.10817.
[124]
Melton-Celsa, A.R.; Kokai-Kun, J.F.; O’Brien, A.D. Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer. Mol. Microbiol. 2002, 43, 207–215, doi:10.1046/j.1365-2958.2002.02733.x.
[125]
Khan, S.; Mian, H.S.; Sandercock, L.E.; Chirgadze, N.Y.; Pai, E.F. Crystal structure of the passenger domain of the Escherichia coli autotransporter EspP. J. Mol. Biol. 2011, 413, 985–1000, doi:10.1016/j.jmb.2011.09.028.
[126]
Otto, B.R.; Sijbrandi, R.; Luirink, J.; Oudega, B.; Heddle, J.G.; Mizutani, K.; Park, S.Y.; Tame, J.R. Crystal structure of hemoglobin protease, a heme binding autotransporter protein from pathogenic Escherichia coli. J. Biol. Chem. 2005, 280, 17339–17345.
[127]
Johnson, T.A.; Qiu, J.; Plaut, A.G.; Holyoak, T. Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease. J. Mol. Biol. 2009, 389, 559–574, doi:10.1016/j.jmb.2009.04.041.
[128]
Leyton, D.L.; Sevastsyanovich, Y.R.; Browning, D.F.; Rossiter, A.E.; Wells, T.J.; Fitzpatrick, R.E.; Overduin, M.; Cunningham, A.F.; Henderson, I.R. Size and conformation limits to secretion of disulfide-bonded loops in autotransporter proteins. J. Biol. Chem. 2011, 286, 42283–42291.
[129]
Xicohtencatl-Cortes, J.; Saldana, Z.; Deng, W.; Castaneda, E.; Freer, E.; Tarr, P.I.; Finlay, B.B.; Puente, J.L.; Giron, J.A. Bacterial macroscopic rope-like fibers with cytopathic and adhesive properties. J. Biol. Chem. 2010, 285, 32336–32342.
[130]
Toth, I.; Cohen, M.L.; Rumschlag, H.S.; Riley, L.W.; White, E.H.; Carr, J.H.; Bond, W.W.; Wachsmuth, I.K. Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect. Immun. 1990, 58, 1223–1231.
[131]
Sheng, H.; Lim, J.Y.; Knecht, H.J.; Li, J.; Hovde, C.J. Role of Escherichia coli O157:H7 virulence factors in colonization at the bovine terminal rectal mucosa. Infect. Immun. 2006, 74, 4685–4693.
Puttamreddy, S.; Cornick, N.A.; Minion, F.C. Genome-wide transposon mutagenesis reveals a role for pO157 genes in biofilm development in Escherichia coli O157:H7 EDL933. Infect. Immun. 2010, 78, 2377–2384, doi:10.1128/IAI.00156-10.
[134]
Ebel, F.; Deibel, C.; Kresse, A.U.; Guzman, C.A.; Chakraborty, T. Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. Infect. Immun. 1996, 64, 4472–4479.
[135]
Al-Hasani, K.; Navarro-Garcia, F.; Huerta, J.; Sakellaris, H.; Adler, B. The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells. PLoS One 2009, 4, e8223.
